Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
Morrow et al.
Molecular Therapy — Oncolytics
Papers
September 2016
Authors and Affiliates
Matthew P Morrow1, Kimberly A Kraynyak1, Albert J Sylvester1, Xuefei Shen1, Dinah Amante1, Lindsay Sakata1, Lamar Parker2, Jian Yan1, Jean Boyer1, Christian Roh1, Laurent Humeau1, Amir S Khan1, Kate Broderick1, Kathleen Marcozzi-Pierce1, Mary Giear1, Jessica Lee1, Cornelia L Trimble3, J Joseph Kim1, Niranjan Y Sardesai1, David B Weiner4 and Mark L Bagarazzi1
1 Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA; 2 Unified Women’s Clinical Research, Winston-Salem, North Carolina, USA; 3 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 4 The Wistar Institute, Philadelphia, Pennsylvania, USA